Literature DB >> 19111162

CD3 antibodies as unique tools to restore self-tolerance in established autoimmunity their mode of action and clinical application in type 1 diabetes.

Sylvaine You1, Sophie Candon, Chantal Kuhn, Jean-François Bach, Lucienne Chatenoud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19111162     DOI： 10.1016/S0065-2776(08)00802-X

Source DB:  PubMed          Journal:  Adv Immunol        ISSN： 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  4 in total

1.  Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.

Authors:  Alix Besançon; Tania Goncalves; Fabrice Valette; Mattias S Dahllöf; Thomas Mandrup-Poulsen; Lucienne Chatenoud; Sylvaine You
Journal:  Diabetologia       Date:  2017-10-13       Impact factor: 10.122

2.  Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic mice.

Authors:  Devangi S Mehta; Rudy A Christmas; Herman Waldmann; Michael Rosenzweig
Journal:  Immunology       Date:  2010-01-06       Impact factor: 7.397

Review 3.  Molecular Mechanisms of T Cells Activation by Dendritic Cells in Autoimmune Diseases.

Authors:  Yu Tai; Qingtong Wang; Heinrich Korner; Lingling Zhang; Wei Wei
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810

Review 4.  Immunotherapy for Parkinson's disease.

Authors:  Aaron D Schwab; Mackenzie J Thurston; Jatin Machhi; Katherine E Olson; Krista L Namminga; Howard E Gendelman; R Lee Mosley
Journal:  Neurobiol Dis       Date:  2020-01-21       Impact factor: 5.996
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.